We are a clinical research group which runs alongside NHS services at Newquay Health Centre.
We work with the pharmaceutical industry to offer clinical trials that evaluate new and exciting medical treatments.
An exciting blood pressure medication called Zilebesiran which needs one injection every six months as an add-on therapy for people with uncontrolled/treatment resistant high blood pressure
A trial of the effect of a new generation GLP1-agonist called retatrutide. This medication is the next generation version of Ozempic and Mounjaro. It is aimed only at people with exisiting or previous heart and kidney conditions who are living with obesity.
A study to evaluate the effect of triple medication inhalers in protecting patients from heart attacks and strokes in the long term
An exciting new trial to evaluate the effect of cannabis extract in patients with chronic low back pain
A trial of lorundrostat, an exciting blood pressure medication, to treat uncontrolled/treatment resistant high blood pressure
A study to evaluate atogepant, a new generation medication, for the treatment of migraine
A new injectable medication for lowering triglycerides (fats) in the blood
A long term trial to find out whether inclisiran, a recently licensed injectable cholesterol medication, can prevent heart attacks and strokes in people with high cholesterol.
A study to evaluate the long-term safety and efficacy of LIB003, a new generation cholesterol lowering medication, in protecting patients from heart attacks and strokes
A trial looking at a fish oil from herring roe as a treatment for mild to moderate psoriasis
Monday - Friday: 8:00am - 6:00pm
Saturday - Sunday: Closed
North Coast Medical Limited is a limited company registered in England and Wales.
Registration number : 11922748. Registered Office: Newquay Health Centre, St Thomas Road, Newquay, Cornwall, TR7 1RU.
ICO reference: ZB152876
Copyright © 2021 North Coast Medical Limited - All Rights Reserved.